Real-life Outcomes of Tenofovir Disoproxil Fumarate Monotherapy in Nucleos(t)ide Analogue-naive and Nucleos(t)ide Analogue-experienced Chronic Hepatitis B Patients: A Single-center Experience

Korkmaz, ONUR; CAGLAN, Figen; AYKIN, Nevil; NAZ, Hasan; TOKA, ONUR

doi:10.4274/vhd.94830

Real-life Outcomes of Tenofovir Disoproxil Fumarate Monotherapy in Nucleos(t)ide Analogue-naive and Nucleos(t)ide Analogue-experienced Chronic Hepatitis B Patients: A Single-center Experience

Korkmaz P., CAGLAN F. C., AYKIN N., NAZ H., TOKA O.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.22, sa.3, ss.92-96, 2016 (ESCI, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 22 Sayı: 3
Basım Tarihi: 2016
Doi Numarası: 10.4274/vhd.94830
Dergi Adı: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.92-96
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Hacettepe Üniversitesi Adresli: Evet

Özet

Objective: The aim of the study was to evaluate the long-term results of treatment efficacy and safety in nucleos(t)ide analogue-naive (NA-naive) and NA-experienced chronic hepatitis B (CHB) patients receiving tenofovir disoproxil fumarate (TDF) therapy.